Immediate Impact

9 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
1 intermediate paper

Works of Anna Chiu being referenced

Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent
2023
Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study
2015

Author Peers

Author Last Decade Papers Cites
Anna Chiu 256 39 150 152 14 517
Chun‐Fu Yeh 164 309 80 21 561
John L. Brusch 211 3 281 80 22 631
Joshua C. Herigon 223 5 190 63 23 545
Filippo Trapani 233 56 195 69 27 581
Marvin A. H. Berrevoets 91 3 160 43 31 464
Jacobus H Sloos 148 3 161 86 13 604
Jennifer Duchon 177 4 224 36 21 545
Maria Amodio-Groton 332 12 217 184 15 504
Danny Benjamin 237 3 231 164 11 634
Richard J. Everts 206 209 195 24 509

All Works

Loading papers...

Rankless by CCL
2026